Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Genetic and genomic approaches to reward and addiction.

Mohn AR, Yao WD, Caron MG.

Neuropharmacology. 2004;47 Suppl 1:101-10. Review.

PMID:
15464129
2.

Experimental genetic approaches to addiction.

Laakso A, Mohn AR, Gainetdinov RR, Caron MG.

Neuron. 2002 Oct 10;36(2):213-28. Review.

3.

Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.

Gainetdinov RR, Mohn AR, Bohn LM, Caron MG.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11047-54.

4.

Genetic animal models: focus on schizophrenia.

Gainetdinov RR, Mohn AR, Caron MG.

Trends Neurosci. 2001 Sep;24(9):527-33. Review.

PMID:
11506886
5.

Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.

Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG.

Neuron. 2001 Apr;30(1):121-34.

7.

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.

Mohn AR, Gainetdinov RR, Caron MG, Koller BH.

Cell. 1999 Aug 20;98(4):427-36.

8.

Phenotypic analysis of mice lacking the highly abundant Purkinje cell- and bipolar neuron-specific PCP2 protein.

Mohn AR, Feddersen RM, Nguyen MS, Koller BH.

Mol Cell Neurosci. 1997 Jan;9(1):63-76.

PMID:
9204480

Supplemental Content

Support Center